Abstract | AIM: METHODS: RESULTS: There was no significant difference in CD4, CD8, CD4/CD8, IL2, IFN-gamma, IL10, WBC, PLT, T-Bil levels between two groups before surgery. Two months after operation, the levels of CD4 (41.2%+/-4.2% vs 34.7%+/-3.8%), CD4/CD8 (1.7+/-0.2 vs 1.0+/-0.2), IFN-gamma (102.3+/-15.9 pg/ml vs 86.5+/-14.8 pg/ml), IL-2(97.2+/-15.6 pg/ml vs 77.6+/-14.5 pg/ml) were increased and those of CD8 (25.6+/-3.9 vs 32.8%+/-4.1%), IL-10 (56.9+/-10.4 pg/ml vs 72.6+/-15.3 pg/ml) were decreased in splenectomy groups as compared with those in non- splenectomy group (P<0.05). WBC and PLT counts in the splenectomy group were 8.9+/-1.6 X 10(9) and 310+/-32 X 10(9), respectively, which were significantly higher than those in non- splenectomy group (3.7+/-1.4 X 10(9) and 104+/-41 X 10(9)) respectively on the 14th post-operative day. T-Bil concentration in the splenectomy group (24+/-7 micromol/L) was significantly lower than that in the non- splenectomy group (37+/-13 micromol/L) on the 7th post-operative day (P<0.05). CONCLUSION:
Splenectomy combined with hepatectomy for HCC associated with cirrhosis is helpful for the recovery of T-lymphocyte subsets and the maintenance of Th1/Th2 cytokine balance.
|
Authors | Zhi-Xin Cao, Xiao-Ping Chen, Zai-De Wu |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 9
Issue 11
Pg. 2460-3
(Nov 2003)
ISSN: 1007-9327 [Print] United States |
PMID | 14606076
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- CD4-CD8 Ratio
- Carcinoma, Hepatocellular
(complications, surgery)
- Cytokines
(blood)
- Female
- Hepatectomy
- Humans
- Leukocyte Count
- Liver Cirrhosis
(complications, surgery)
- Liver Neoplasms
(complications, surgery)
- Male
- Middle Aged
- Platelet Count
- Splenectomy
- Thrombocytopenia
(etiology, surgery)
|